Glucagon-like peptide-2 (GLP-2) is a potent intestinal growth factor derived from 19 enteroendocrine L-cells. Although food intake is known to increase GLP-2 secretion, its 20 regulatory mechanisms are largely unknown owing to its very short half-life in venules. The 21 aims of this study were to compare the effects of luminal nutrients on the stimulation of 22 GLP-2 secretion in vivo using lymph samples and to clarify the involvement of the sweet 23 taste receptor in this process in vitro. Lymph samples were collected from the thoracic duct 24 after bolus administration of dietary lipids or sweetening agents into the duodenum of rats. 
were used for comparison of GLP-2 concentrations between blood and lymph. In these 134 animals, only a feeding tube was inserted into the duodenum. Animals were anesthetized 135 with pentobarbital 2 h after a 3-mL bolus of saline or perilla oil, and blood was collected by 136 cardiac puncture with a 25-G needle. Blood samples were centrifuged to separate plasma 137 and stored -20°C, in the same manner as lymph samples. 138
Cell culture and GLP-2 secretion. Human NCI-H716 cells were obtained from the American 139
Type Culture Collection (Manassas, VA, USA). For proliferation and maintenance, cells 140 were grown in suspension in RPMI 1640 medium supplemented with 5% fetal bovine serum, 141 100 IU/mL penicillin, and 100 g/mL streptomycin. Two days before each experiment, the 142 cells were seeded into 96-well plates precoated with poly-L-lysine (1 × 10 5 cells/well). The 143 culture medium was replaced with HEPES buffer before the experiment, and the cells were 144 incubated for 1 h at 37°C with test agents. αLA, glucose, sucralose, and PALSWEET were 145 GLP-2 concentrations in the blood and lymph before and 2 h after perilla oil infusion were 168 shown in Fig. 1 . The concentration of GLP-2 in the lymph was significantly higher than that 169 in the blood for both time points (before infusion, 1.34 ± 0.25 ng/mL vs. 0.54 ± 0.08 ng/mL, 170 respectively; after infusion, 4.76 ± 1.09 ng/mL vs. 1.49 ± 0.14 ng/mL, respectively). Increased 171 GLP-2 concentrations after perilla oil infusion were more obvious in lymph samples, 172
indicating that lymphatic sampling may be more sensitive than blood sampling as a means 173 of measuring GLP-2 secretion.
Increased GLP-2 output was observed from 2-8 h following perilla oil injection and from 2-4 181 h after injection for both glucose and sucralose solutions. For all reagents, the mean output 182 peaked at 2 h after the injection. Based on these results, subsequent studies used samples 183 collected at 2 h following administration of the indicated reagents. 184 GLP-2 outputs induced by perilla oil, glucose solution, and dextrin solution were compared 185 before and after infusion (Fig. 3) . A 3-mL-dose of perilla oil significantly increased GLP-2 186 output (9.02 ± 1.27 ng/h) compared to saline injection (1.51 ± 0.45 ng/h), while 0.1 ~ 1-mL 187 doses of perilla oil did not elicit the same effect, suggesting that perilla oil induces 188 dose-dependent GLP-2 secretion (Fig. 3A) Glucose-induced GLP-2 output was increased 189 when concentrations more than 5% of glucose was administered (Fig.3B ), but GLP-2 output 190 apparently declined since 10%. Then we examined by using 5% and 10% dextrin solution, a 191 glucose polymer that has a 83-fold greater molecular weight than that of glucose, to avoid 192 the effect of osmotic stress induced by glucose solution. In this setting, 5% dextrin solution 193 increased GLP-2 output comparable to 5% glucose solution and 10% dextrin solution 194 induced a marked increase in GLP-2, suggesting GLP-2 secretion induced by glucose may 195 not be due to its large degree of osmotic effect (Fig.3C) . The effects of αLA, a major component of perilla oil, and the effects of 3 different sweeteners 232
(that showed enhanced GLP-2 release in in vivo studies) on GLP-2 secretion in human 233 enteroendocrine NCI-H716 cells are shown in Fig. 7 . αLA, glucose, and sucralose elicited 234 dose-dependent increases in GLP-2 secretion (Fig. 7A) . Among these agents, glucose-and 235 sucralose-induced GLP-2 secretion was inhibited by 500 mM lactisole, an antagonizing 236 inhibitor of the sweetness receptor T1R3, while αLA-induced GLP-2 secretion was not 237 inhibited by lactisole, suggesting that T1R3 signaling may be involved in glucose-and 238 sucralose-mediated effects but not in αLA-mediated effects. Cocktails of αLA and either 239 glucose or sucralose were more effective at inducing GLP-2 than each sweetener alone (Fig.  240   7B) . Intriguingly, GLP-2 secretion induced by combined treatment with this cocktail and 241 lactisole was lower than that induced by each sweetener alone, despite the presence of αLA. PALSWEET, αLA, and lactisole was comparable to that induced by PALSWEET alone, 248 despite the presence of αLA (Fig. 7D) . Lactisole itself did not affect GLP-2 secretion (Fig. 7E) . (25), our results showed that mixed infusions of perilla oil and glucose or 329 sweeteners induced GLP-2 secretion at a similar or greater level than perilla oil alone, even 330 though which contains a higher amount of calories. That is, although the total calories in a 331 mixture of 2 mL perilla oil and 1 mL 5% glucose solution was no more than three-fourths of 332 that in 3 mL of perilla oil, the mixture induced nearly an equal amount of GLP-2 secretion 333 as perilla oil did. In addition, GLP-2 output induced by the mixture, which contained 334 sucralose or PALSWEET, was significantly greater than that by perilla oil alone. These 335 results suggest the existence of receptors responding to sweet-tasting agents may elicit some 
